This study identified Faecalibaculum rodentium as a novel probiotic that suppresses colorectal cancer (CRC) via acetate, which enhances CD8+ T-cell immunity by blocking PDPN-CLEC-2 and induces tumor cell apoptosis through PI3K/AKT/mTOR pathway. Here, MTOR is linked to colorectal carcinoma.